1
|
Polymorphisms of the HTR2C gene and antipsychotic-induced weight gain: an update and meta-analysis.
|
Pharmacogenomics
|
2010
|
1.04
|
2
|
A common polymorphism in the cannabinoid receptor 1 (CNR1) gene is associated with antipsychotic-induced weight gain in Schizophrenia.
|
Neuropsychopharmacology
|
2010
|
0.99
|
3
|
ANK3, CACNA1C and ZNF804A gene variants in bipolar disorders and psychosis subphenotype.
|
World J Biol Psychiatry
|
2011
|
0.88
|
4
|
Mixture regression analysis on age at onset in bipolar disorder patients: investigation of the role of serotonergic genes.
|
Eur Neuropsychopharmacol
|
2010
|
0.87
|
5
|
The pharmacogenetics of antipsychotic-induced adverse events.
|
Curr Opin Psychiatry
|
2013
|
0.86
|
6
|
Abnormal interneuron development in disrupted-in-schizophrenia-1 L100P mutant mice.
|
Mol Brain
|
2013
|
0.86
|
7
|
Role of 5-HT(2C) receptor gene variants in antipsychotic-induced weight gain.
|
Pharmgenomics Pers Med
|
2011
|
0.85
|
8
|
Association between the DAOA/G72 gene and bipolar disorder and meta-analyses in bipolar disorder and schizophrenia.
|
Bipolar Disord
|
2011
|
0.84
|
9
|
Childhood aggression, callous-unemotional traits and oxytocin genes.
|
Eur Child Adolesc Psychiatry
|
2012
|
0.84
|
10
|
COMT Val158Met variant and functional haplotypes associated with childhood ADHD history in women with bulimia nervosa.
|
Prog Neuropsychopharmacol Biol Psychiatry
|
2011
|
0.83
|
11
|
Antipsychotics, dopamine D₂ receptor occupancy and clinical improvement in schizophrenia: a meta-analysis.
|
Schizophr Res
|
2012
|
0.82
|
12
|
Genetics in schizophrenia: where are we and what next?
|
Dialogues Clin Neurosci
|
2010
|
0.81
|
13
|
Association study of GRIK1 gene polymorphisms in schizophrenia: case-control and family-based studies.
|
Hum Psychopharmacol
|
2012
|
0.81
|
14
|
Study of the catechol-o-methyltransferase (COMT) gene with high aggression in children.
|
Aggress Behav
|
2012
|
0.81
|
15
|
Dopamine D4 and D5 receptor gene variant effects on clozapine response in schizophrenia: replication and exploration.
|
Prog Neuropsychopharmacol Biol Psychiatry
|
2011
|
0.81
|
16
|
Association of the orphan nuclear receptor NR4A1 with tardive dyskinesia.
|
Psychiatr Genet
|
2010
|
0.80
|
17
|
Fat mass- and obesity-associated (FTO) gene and antipsychotic-induced weight gain: an association study.
|
Neuropsychobiology
|
2014
|
0.80
|
18
|
Association of a functional polymorphism in neuropeptide Y with antipsychotic-induced weight gain in schizophrenia patients.
|
J Clin Psychopharmacol
|
2013
|
0.79
|
19
|
Association study of polymorphisms in insulin induced gene 2 (INSIG2) with antipsychotic-induced weight gain in European and African-American schizophrenia patients.
|
Hum Psychopharmacol
|
2010
|
0.79
|
20
|
The role of genetic variants in genes regulating the oxytocin-vasopressin neurohumoral system in childhood-onset aggression.
|
Psychiatr Genet
|
2014
|
0.79
|
21
|
The AmpliChip® CYP450 test and response to treatment in schizophrenia and obsessive compulsive disorder: a pilot study and focus on cases with abnormal CYP2D6 drug metabolism.
|
Genet Test Mol Biomarkers
|
2012
|
0.78
|
22
|
Summaries from the XVIII World Congress of Psychiatric Genetics, Athens, Greece, 3-7 October 2010.
|
Psychiatr Genet
|
2011
|
0.78
|
23
|
Analysis of 34 candidate genes in bupropion and placebo remission.
|
Int J Neuropsychopharmacol
|
2012
|
0.78
|
24
|
Parent of origin effect and differential allelic expression of BDNF Val66Met in suicidal behaviour.
|
World J Biol Psychiatry
|
2010
|
0.78
|
25
|
Possible association of the DRD4 gene with a history of attention-deficit/hyperactivity disorder in women with bulimia nervosa.
|
Int J Eat Disord
|
2012
|
0.77
|
26
|
Association study of polymorphisms in cholecystokinin gene and its receptors with antipsychotic induced weight gain in schizophrenia patients.
|
Prog Neuropsychopharmacol Biol Psychiatry
|
2010
|
0.77
|
27
|
The Role of the Catechol-o-Methyltransferase (COMT) GeneVal158Met in Aggressive Behavior, a Review of Genetic Studies.
|
Curr Neuropharmacol
|
2015
|
0.77
|
28
|
MDR1 gene in tardive dyskinesia scale scores: comparison of strategies for quantitative trait haplotype analysis.
|
Schizophr Res
|
2009
|
0.76
|
29
|
Meta-analysis and association of brain-derived neurotrophic factor (BDNF) gene with obsessive-compulsive disorder.
|
Psychiatr Genet
|
2015
|
0.76
|
30
|
Genetic variation in the GCG and in the GLP1R genes and antipsychotic-induced weight gain.
|
Pharmacogenomics
|
2014
|
0.76
|
31
|
Association and CpG SNP analysis of HTR4 polymorphisms with suicidal behavior in subjects with schizophrenia.
|
J Neural Transm (Vienna)
|
2012
|
0.76
|
32
|
Gene-gene interaction analyses between NMDA receptor subunit and dopamine receptor gene variants and clozapine response.
|
Pharmacogenomics
|
2011
|
0.76
|
33
|
Age at onset of schizophrenia: cannabis, COMT gene, and their interactions.
|
Schizophr Res
|
2013
|
0.76
|
34
|
Rapporteur summaries of plenary, symposia, and oral sessions from the XXIIIrd World Congress of Psychiatric Genetics Meeting in Toronto, Canada, 16-20 October 2015.
|
Psychiatr Genet
|
2016
|
0.75
|
35
|
Summaries from the XIX World Congress of Psychiatric Genetics, Washington, DC, September 10-14, 2011.
|
Am J Med Genet B Neuropsychiatr Genet
|
2012
|
0.75
|
36
|
Possible association between the prolactin receptor gene and callous-unemotional traits among aggressive children.
|
Psychiatr Genet
|
2016
|
0.75
|
37
|
Investigation of TSPO variants in schizophrenia and antipsychotic treatment outcomes.
|
Pharmacogenomics
|
2015
|
0.75
|